EP3006439A4 - BICYCLIC DERIVATIVE WITH PYRIMIDINE RING AND METHOD OF MANUFACTURING THEREOF - Google Patents

BICYCLIC DERIVATIVE WITH PYRIMIDINE RING AND METHOD OF MANUFACTURING THEREOF

Info

Publication number
EP3006439A4
EP3006439A4 EP14800740.4A EP14800740A EP3006439A4 EP 3006439 A4 EP3006439 A4 EP 3006439A4 EP 14800740 A EP14800740 A EP 14800740A EP 3006439 A4 EP3006439 A4 EP 3006439A4
Authority
EP
European Patent Office
Prior art keywords
preparation
method therefor
pyrimidine ring
derivative containing
containing pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14800740.4A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3006439A1 (en
Inventor
Jae Young Sim
Myung Hun Cha
Tae Kyun Kim
Young Ae Yoon
Dong Hoon Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuhan Corp
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Publication of EP3006439A1 publication Critical patent/EP3006439A1/en
Publication of EP3006439A4 publication Critical patent/EP3006439A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP14800740.4A 2013-05-24 2014-05-23 BICYCLIC DERIVATIVE WITH PYRIMIDINE RING AND METHOD OF MANUFACTURING THEREOF Withdrawn EP3006439A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020130058843A KR101657616B1 (ko) 2013-05-24 2013-05-24 피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법
PCT/KR2014/004636 WO2014189331A1 (ko) 2013-05-24 2014-05-23 피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법

Publications (2)

Publication Number Publication Date
EP3006439A1 EP3006439A1 (en) 2016-04-13
EP3006439A4 true EP3006439A4 (en) 2016-11-02

Family

ID=51933817

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14800740.4A Withdrawn EP3006439A4 (en) 2013-05-24 2014-05-23 BICYCLIC DERIVATIVE WITH PYRIMIDINE RING AND METHOD OF MANUFACTURING THEREOF

Country Status (12)

Country Link
US (1) US20170152241A9 (ja)
EP (1) EP3006439A4 (ja)
JP (1) JP2016520098A (ja)
KR (1) KR101657616B1 (ja)
CN (1) CN105452238A (ja)
AU (1) AU2014269229B2 (ja)
BR (1) BR112015029156A2 (ja)
CA (1) CA2913592A1 (ja)
HK (1) HK1218536A1 (ja)
MX (1) MX2015016033A (ja)
RU (1) RU2015155292A (ja)
WO (1) WO2014189331A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110317176A (zh) * 2019-07-04 2019-10-11 沈阳药科大学 2-氨基嘧啶类化合物及其用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007058989A2 (en) * 2005-11-14 2007-05-24 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of voltage gated ion channels
WO2008119792A1 (en) * 2007-04-02 2008-10-09 Palau Pharma, S. A. Pyrrolopyrimidine derivatives as jak3 inhibitors
WO2009131687A2 (en) * 2008-04-22 2009-10-29 Portola Pharmaceuticals, Inc. Inhibitors of protein kinases
WO2010034740A1 (en) * 2008-09-23 2010-04-01 Palau Pharma, S.A. (r)-3-(n,n-dimethylamino)pyrrolidine derivatives

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
CZ284687B6 (cs) 1986-04-30 1999-02-17 Dainippon Pharmaceutical Co., Ltd. Substituovaný benzamidový derivát, způsob jeho výroby a farmaceutický prostředek na jeho bázi
GB9005014D0 (en) 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
HUT64023A (en) 1991-03-22 1993-11-29 Sandoz Ag Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
DE69530989T2 (de) * 1994-08-13 2004-05-19 Yuhan Corp. Neue pyrimidinderivate und verfahren zu ihrer herstellung
AU2004272437A1 (en) * 2003-09-09 2005-03-24 Ono Pharmaceutical Co., Ltd. CRF antagonists and heterobicyclic compounds
KR101682417B1 (ko) * 2011-02-25 2016-12-06 주식회사유한양행 다이아미노피리미딘 유도체 및 그의 제조방법
JP5890436B2 (ja) * 2011-02-25 2016-03-22 ユーハン・コーポレイションＹＵＨＡＮ Ｃｏｒｐｏｒａｔｉｏｎ ジアミノピリミジン誘導体及びその製造方法
MD20140023A2 (ro) * 2011-09-22 2014-06-30 Pfizer Inc. Derivaţi de pirolpirimidină şi purină

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007058989A2 (en) * 2005-11-14 2007-05-24 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of voltage gated ion channels
WO2008119792A1 (en) * 2007-04-02 2008-10-09 Palau Pharma, S. A. Pyrrolopyrimidine derivatives as jak3 inhibitors
WO2009131687A2 (en) * 2008-04-22 2009-10-29 Portola Pharmaceuticals, Inc. Inhibitors of protein kinases
WO2010034740A1 (en) * 2008-09-23 2010-04-01 Palau Pharma, S.A. (r)-3-(n,n-dimethylamino)pyrrolidine derivatives

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2014189331A1 *
TARI LESLIE W ET AL: "Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 23, no. 5, 5 December 2012 (2012-12-05), pages 1529 - 1536, XP028976455, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2012.11.032 *

Also Published As

Publication number Publication date
MX2015016033A (es) 2016-08-03
EP3006439A1 (en) 2016-04-13
US20160090374A1 (en) 2016-03-31
AU2014269229B2 (en) 2017-03-02
WO2014189331A1 (ko) 2014-11-27
RU2015155292A (ru) 2017-06-30
CN105452238A (zh) 2016-03-30
AU2014269229A1 (en) 2015-12-17
BR112015029156A2 (pt) 2017-07-25
JP2016520098A (ja) 2016-07-11
US20170152241A9 (en) 2017-06-01
CA2913592A1 (en) 2014-11-27
HK1218536A1 (zh) 2017-02-24
KR101657616B1 (ko) 2016-09-19
KR20140137810A (ko) 2014-12-03

Similar Documents

Publication Publication Date Title
IL278214A (en) Preparations of azaindole compounds, methods for their preparation and their uses
HK1221720A1 (zh) 喹唑啉衍生物及其製備方法
HK1206722A1 (en) New bicyclic derivatives
EP3073870A4 (en) Hip seat carrier set
HK1209324A1 (en) Nanozymes, methods of making nanozymes, and methods of using nanozymes
EP2995838A4 (en) Inner ring
HK1218120A1 (zh) 三環苯並氧雜硼化合物、其製備方法與應用
SG11201602579SA (en) Bicyclic alkyne derivatives and uses thereof
EP3065712A4 (en) Microparticles, methods for their preparation and use
EP2805954A4 (en) 7-SUBSTITUTED HANFANGICHIN B DERIVATIVE AND MANUFACTURING METHOD AND USE THEREOF
EP2952519A4 (en) PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
EP2957660A4 (en) PISTON SEGMENT AND METHOD FOR PRODUCING THE SAME
HUE040536T2 (hu) Eljárás halogén-N,N-dimetilbenzilaminok elõállítására
EP3081554A4 (en) Method for preparing silodosin and intermediate thereof
EP3015455A4 (en) 4-benzyl-1-phenethyl-piperazine-2,6-dione preparation method, and intermediate and preparation method thereof
EP2987794A4 (en) VINBLASTINE DERIVATIVES, PROCESS FOR THEIR SYNTHESIS AND THEIR APPLICATION
IL245018A (en) A synthetic intermediate of maxaccalitol, a method for its preparation and use
ZA201603682B (en) Taxanes compounds, preparation method therefor, and uses thereof
HK1218536A1 (zh) 含嘧啶環的二環衍生物及其製備方法
EP3072527A4 (en) Immunosuppressant
EP3057926A4 (en) Methods and intermediates for preparing macrolactams
HK1244814A1 (zh) 一種薯蕷皂苷元-3-位衍生物及其製備方法和用途
PL2848366T3 (pl) Tokarka oraz sposób
PL2835388T3 (pl) Sposób wytwarzania roztworów aminoplastów
TWM476025U (en) Retaining ring

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20151224

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20161006

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 403/04 20060101AFI20160929BHEP

Ipc: C07D 401/04 20060101ALI20160929BHEP

Ipc: A61K 31/506 20060101ALI20160929BHEP

Ipc: A61P 1/04 20060101ALI20160929BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20170426